With survival expectation that of age-matched controls and given excellent response and
worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly …

Since the introduction of tyrosine kinase inhibitors (TKIs) at the beginning of the millennium,
the outlook for patients with chronic myeloid leukemia (CML) has improved remarkably. As …

Abstract Purpose of Review The goal of this review is to summarize what is known about
pregnancy in women with chronic myeloid leukemia (CML): there are very few guidelines …

The success of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid
leukaemia (CML) has resulted in a return to a normal life expectancy for the majority of …

The management of patients with chronic myeloid leukemia (CML) during pregnancy has
become recently a matter of continuous debate. The introduction of the Tyrosine Kinase …

Introduction: Since the introduction of tyrosine kinase inhibitors (TKIs) therapy, chronic
myeloid leukemia (CML), has moved from a fatal illness to a manageable disease with a …

Management of pregnant patients with chronic myelogenous leukemia (CML) is challenging.
Some of the factors that need to be considered include stage of pregnancy, disease status …

Introduction The introduction of tyrosine kinase inhibitors (TKIs) has revolutionized the
therapy of chronic myeloid leukemia (CML). Although the efficacy of TKIs is beyond dispute …

Background The aim of this study was to explore outcomes of planned pregnancy in female
patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitors (TKIs). Materials …

Tyrosine kinase inhibitors (TKIs) are teratogenic. Chronic myeloid leukemia (CML) is
increasingly identified in younger patients who wish to conceive, the management of CML …